TrialEndocrine-related cancer2012

Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours.

Anna Koumarianou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.